Home INDUSTRIAL FRONT Industry Updates Textile Trident Q1 FY27 Results: Net Profit Rises 13% YoY
Textile

Trident Q1 FY27 Results: Net Profit Rises 13% YoY

Share
Share

Trident Limited’s Q1 FY27 net profit rose 13% year-on-year to Rs 158 crore, as the Ludhiana-headquartered home textiles and paper major posted consolidated revenue of Rs 1,787 crore for the quarter ended June 30, 2026. Consolidated total income climbed to Rs 1,803 crore, up 9% sequentially and 4% year-on-year, with EBITDA rising a sharp 27% quarter-on-quarter to Rs 316 crore.

Trident, one of India’s largest integrated home textile manufacturers with operations spanning yarn, terry towels, bedsheets and paper and chemicals, reported broad-based segment growth. The Yarn business contributed consolidated revenue of Rs 954 crore, the Home Textile business added Rs 941 crore, and the Paper and Chemicals segment brought in Rs 297 crore, reflecting Trident’s diversified base across export-facing textile products and domestic paper manufacturing.

Why Did Trident’s EBITDA Jump 27% Sequentially in Q1 FY27?

Trident’s sharp sequential EBITDA improvement in Q1 FY27 reflects better capacity utilisation across its yarn and home textile plants, alongside improved realisations as global demand for terry towels and bedsheets picked up heading into the second half of calendar 2026. The company’s home textile exports, largely bound for the US and European retail markets, have also benefited from steadier cotton input costs compared with the volatility seen in prior quarters, helping protect margins even as topline growth stayed in the mid-single digits.

What Does This Mean for India’s Home Textile Exporters?

Trident’s results add to a growing list of positive Q1 FY27 updates from India’s home textile and yarn exporters, including Sangam India and KPR Mill, suggesting the sector’s margin recovery is broadening beyond any single company. The trend comes as India’s textile exporters position themselves to capture additional market share following the India-UK Comprehensive Economic and Trade Agreement, which took effect on July 15, 2026 and is expected to remove longstanding tariff disadvantages against competing exporters in Bangladesh and Vietnam.

Market Reaction and Industry Response

Trident shares traded firmly following the release of its Q1 FY27 investor presentation, with analysts highlighting the sequential EBITDA jump as evidence of improving operating leverage across its yarn and home textile businesses. The results reinforced a broader rally in textile stocks that has picked up pace through June and July 2026, as Motilal Oswal and other brokerages turned more constructive on apparel and home textile names citing improved export order visibility.

What Happens Next for Trident?

Trident’s management will look to sustain the current momentum in its home textile export business through the festive and winter demand season in key markets like the US and Europe, while continuing to optimise its paper and chemicals segment. Investors will watch whether the 27% sequential EBITDA gain proves durable into the September quarter, particularly as new trade agreement benefits start to filter through into fresh export orders.

Frequently Asked Questions

What were Trident’s Q1 FY27 results?

Trident reported consolidated total income of Rs 1,803 crore and net profit of Rs 158 crore, up 13% year-on-year, for the quarter ended June 30, 2026, with consolidated EBITDA of Rs 316 crore, up 27% sequentially.

What are Trident’s main business segments?

Trident operates across Yarn, Home Textile (terry towels and bedsheets) and Paper and Chemicals segments, with Q1 FY27 consolidated revenue of Rs 954 crore, Rs 941 crore and Rs 297 crore respectively from each.

How does the India-UK trade deal affect Trident?

The India-UK Comprehensive Economic and Trade Agreement, effective July 15, 2026, removes tariff disadvantages on Indian textile exports to the UK, potentially benefiting exporters like Trident that supply home textile products to Western retail markets.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *